慢性肝炎-B (CHB) 患者群体中抗病毒治疗的预测因素
1Experimental and Public Health Laboratory, Department of Zoology, University of Lucknow, Lucknow, U.P. India.
概括
这项研究研究了慢性乙型肝炎 (CHB) 患者的乙型肝炎病毒 (HBV) 生物标志物. 结果显示HBeAg与抗病毒疗法有显著的关联,指导HBsAg阳性个体的治疗决策.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 临床生物化学 临床生物化学
背景情况:
- 慢性乙型肝炎 (CHB) 是一种肝脏疾病,可以用抗病毒药物治疗.
- 乙型肝炎病毒 (HBV) DNA,肝酶,HBeAg和HBeAb是治疗CHB治疗决策的关键指标.
研究的目的:
- 在CHB感染中确定B型肝炎包膜抗体 (HBeAb) 的预后值.
- 探索HB病毒抗原,HB抗体和肝酶在CHB患者治疗中的关系.
主要方法:
- 该研究包括了所有乙型肝炎表面抗原 (HBsAg) 阳性患者.
- 数据提取集中在与抗病毒疗法相关的生化标志物上.
主要成果:
- 发现抗病毒药物和病毒抗原之间存在关联.
- HBeAg与抗病毒疗法显著相关 (p=0.022).
- 最高的HBeAg阳性发生在15-30岁年龄组中.
结论:
- 生物标志物对于管理HBsAg阳性患者至关重要.
- 该研究为将特定指标纳入HBV治疗方案提供了洞察力.
更多相关视频
相关概念视频
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Hepatic Drug Excretion: Influencing Factors
512
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
512


